~ AlphaMD Your lab numbers look perfect on paper, but you still feel like garbage
This article covers what the existing research shows and where the evidence gaps are
Its mechanism of action, stimulating the patients own GH release, offers a more physiologic alternative to direct recombinant GH injections, potentially with a different side effect profile
The TRIUMPH Phase 3 program uses 9 mg and 12 mg as the primary therapeutic doses, with a 4 mg maintenance dose being explored for weight maintenance after initial loss
This receptor activation results in: Rapid, pulsatile increases in GH secretion Amplification of sleep-related GH peaks Synergistic interaction with Growth Hormone-Releasing Hormone (GHRH) pathways The end result is elevated circulating levels of GH and IGF-1 , which support muscle growth, fat metabolism, and tissue repair